【レポートの概要（一部）】
Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 6
Introduction 7
Cancer Pain 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by BRIC Nations 16
Clinical Trials by G7 Nations 17
Clinical Trials in G7 Nations by Trial Status 18
Clinical Trials by E7 Nations 19
Clinical Trials in E7 Nations by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Unaccomplished Trials of Cancer Pain 24
Subjects Recruited Over a Period of Time 29
Prominent Sponsors 30
Top Companies Participating in Cancer Pain Therapeutics Clinical Trials 32
Prominent Drug Comparison 34
Clinical Trial Profiles 35
Clinical Trial Overview of Top Companies 35
GW Pharmaceuticals plc 35
Clinical Trial Overview of GW Pharmaceuticals plc 35
Mundipharma International Limited 36
Clinical Trial Overview of Mundipharma International Limited 36
Teikoku Seiyaku Co., Ltd. 37
Clinical Trial Overview of Teikoku Seiyaku Co., Ltd. 37
Alza Corporation 38
Clinical Trial Overview of Alza Corporation 38
Kyowa Hakko Kirin Co., Ltd. 39
Clinical Trial Overview of Kyowa Hakko Kirin Co., Ltd. 39
Johnson & Johnson 40
Clinical Trial Overview of Johnson & Johnson 40
Janssen Korea Ltd. 41
Clinical Trial Overview of Janssen Korea Ltd. 41
Cephalon, Inc. 42
Clinical Trial Overview of Cephalon, Inc. 42
Pfizer Inc. 43
Clinical Trial Overview of Pfizer Inc. 43
Archimedes Development Limited 44
Clinical Trial Overview of Archimedes Development Limited 44
Akela Pharma Inc. 45
Clinical Trial Overview of Akela Pharma Inc. 45
Shionogi & Co., Ltd. 46
Clinical Trial Overview of Shionogi & Co., Ltd. 46
Taiho Pharmaceutical Co., Ltd. 47
Clinical Trial Overview of Taiho Pharmaceutical Co., Ltd. 47
WEX Pharmaceuticals Inc. 48
Clinical Trial Overview of WEX Pharmaceuticals Inc. 48
Janssen Research & Development, LLC 49
Clinical Trial Overview of Janssen Research & Development, LLC 49
BioDelivery Sciences International, Inc. 50
Clinical Trial Overview of BioDelivery Sciences International, Inc. 50
Endo Health Solutions Inc. 51
Clinical Trial Overview of Endo Health Solutions Inc. 51
Mitsubishi Tanabe Pharma Corporation 52
Clinical Trial Overview of Mitsubishi Tanabe Pharma Corporation 52
Mertiva AB 53
Clinical Trial Overview of Mertiva AB 53
ProStrakan Group plc 54
Clinical Trial Overview of ProStrakan Group plc 54
Clinical Trial Overview of Top Institutes / Government 55
National Cancer Institute 55
Clinical Trial Overview of National Cancer Institute 55
Memorial Sloan Kettering Cancer Center 56
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 56
Alberta Health Services 57
Clinical Trial Overview of Alberta Health Services 57
Norwegian University of Science and Technology 58
Clinical Trial Overview of Norwegian University of Science and Technology 58
Assistance Publique – Hopitaux de Paris 59
Clinical Trial Overview of Assistance Publique – Hopitaux de Paris 59
Tata Memorial Hospital 60
Clinical Trial Overview of Tata Memorial Hospital 60
Erasmus MC 61
Clinical Trial Overview of Erasmus MC 61
Mayo Clinic 62
Clinical Trial Overview of Mayo Clinic 62
The Royal Marsden NHS Foundation Trust 63
Clinical Trial Overview of The Royal Marsden NHS Foundation Trust 63
Federal University of Sao Paulo 64
Clinical Trial Overview of Federal University of Sao Paulo 64
H. Lee Moffitt Cancer Center & Research Institute 65
Clinical Trial Overview of H. Lee Moffitt Cancer Center & Research Institute 65
University of California, San Diego 66
Clinical Trial Overview of University of California, San Diego 66
Sidney Kimmel Comprehensive Cancer Center 67
Clinical Trial Overview of Sidney Kimmel Comprehensive Cancer Center 67
National Cancer Center 68
Clinical Trial Overview of National Cancer Center 68
Hiroshima University Hospital 69
Clinical Trial Overview of Hiroshima University Hospital 69
Yale University 70
Clinical Trial Overview of Yale University 70
Policlinico Universitario “Agostino Gemelli” 71
Clinical Trial Overview of Policlinico Universitario “Agostino Gemelli” 71
Tel-Aviv Sourasky Medical Center 72
Clinical Trial Overview of Tel-Aviv Sourasky Medical Center 72
Roswell Park Cancer Institute 73
Clinical Trial Overview of Roswell Park Cancer Institute 73
Kyoto University 74
Clinical Trial Overview of Kyoto University 74
Five Key Clinical Profiles 75
Appendix 106
Abbreviations 106
Definitions 106
Research Methodology 107
Secondary Research 107
About GlobalData 108
Contact Us 108
Disclaimer 108
Source 109
【レポート販売概要】
■ タイトル：Cancer Pain：グローバル臨床試験レビューH1, 2013■ 英文：Cancer Pain Global Clinical Trials Review, H1, 2013
■ 発行日：2013年4月30日
■ 調査会社：GlobalData
■ 商品コード：GDATA403160815
■ 調査対象地域：グローバル
- Pruritus：グローバル臨床試験レビューH2, 2013Pruritus Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Pruritus Global Clinical Trials Review, H2, 2013" provides data on the Pruritus clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Pruritus. It includes an overview of the trial numbers and their recruitment status as per the site of trial condu …
- ディープサイクルバッテリーの世界市場2017-2021About Deep Cycle Batteries Deep cycle batteries can be classified into FLA and VRLA batteries. One of the advantages of deep cycle VRLA batteries is that they can be substituted in any FLA battery application, where FLA batteries may or may not deliver the best of results. Deep cycle VRLA batteries provide ideal solutions because of their unique benefits and features. These batteries are colloquia …
- 世界のインテリジェントビルディングにおけるM2M通信動向（2012-2016）TechNavio's analysts forecast the Global Machine-to-Machine Communication in Intelligent Buildings market to grow at a CAGR of 22.36 percent over the period 2012-2016. One of the key factors contributing to this market growth is growing popularity of 3G and 4G networks. The Global Machine-to-Machine Communication in Intelligent Buildings market has also been witnessing increased adoption of cloud- …
- 脳神経外科用装置の世界市場予測（～2024年）“The neurosurgery devices market is projected to grow at a CAGR of 13.0% during the forecast period.”The neurosurgery devices market is projected to reach USD 13.5 billion by 2024 from USD 7.3 billion in 2019, at a CAGR of 13.0% during the forecast period. Growth in this market can be attributed to the rising prevalence of neurological disorders, efforts to develop the application base for neuromo …
- エアフィルターの世界市場：吸気フィルター、車室内エアフィルターThe function of the intake air filter is to restrict the entry of airborne contaminants in the engine. Cellulose and synthetic are two kinds of filter media commonly used in intake air filters. Cellulose is conventional filter media and is estimated to hold the largest market share; whereas synthetic is emerging technology and is slowly gaining popularity in the market owing to its high filtration …
- グローバル・エネルギー産業動向：Looking at the Global Energy IndustryThe global energy industry has explored many options to meet the growing energy needs of industrialized economies wherein production demands are to be met with supply of power from varied energy resources worldwide. There has been a clearer realization of the finite nature of oil resources and the ever higher pushing demand for energy. The world has yet to stabilize on the complex geopolitical und …
- 世界のプレハブ式ビル市場における動向と市場機会（～2017）In terms of growth, the global prefabricated buildings market recorded a review-period (2008?2012) CAGR of 1.92%. The growth was subdued by a 15% decline in the market in 2009, due to the financial crisis. Construction activity slowed, and consequently the demand for prefabricated buildings declined. The market is expected to record a forecast-period CAGR of 8.59% due to construction industry grow …
- HPDA（高性能データ分析）の世界市場予測：ハードウェア、ソフトウェア、サービスThe High Performance Data Analytics market is estimated to grow from USD 25.71 Billion in 2016 to USD 78.26 Billion by 2021, at a high Compound Annual Growth Rate (CAGR) of 24.9% during the forecast period. The proliferation of open source frameworks (Hadoop) for big data analytics and the ability of powerful High Performance Computing (HPC) systems to process data at higher resolutions are the dr …
- 世界のモバイルゲーム市場：プラットフォーム別、地域別Global Mobile Gaming Market: About this market Technavio’s mobile gaming market analysis considers sales from both online and offline platform. Our study also finds the sales of mobile gaming in APAC, Europe, North America, South America, and MEA. In 2019, the online mobile gaming segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such …
- 無水マレイン酸の世界市場：不飽和ポリエステル樹脂、1,4-ブタンジオール（BDO）、添加剤、コポリマー用途About Maleic Anhydride Maleic anhydride, manufactured through the oxidation of butane or benzene, is an organic, white crystalline solid with an acrid odor. Maleic anhydride has limited applications, while its derivatives possess versatile applications. The majority of maleic anhydride manufactured is used in unsaturated polyester resin, while other applications include BDO, copolymers, additives, …
- 顧客分析ソリューションの世界市場In customer analytics, each solution and service plays an important role in the overall market. These solutions and services support a broad spectrum of multi-functional applications such as customer acquisition, retention, loyalty management, behavioral analysis, predictive analysis, pattern analysis, customer segmentation, and various others. The customer analytics is the process of integrating …
- 医療IT統合の世界市場予測：インターフェースエンジン、医療機器統合、メディア統合“The healthcare IT integration solutions market is projected to grow at a CAGR of 10.9%.”The global healthcare IT integration solutions market is projected to reach USD 5.3 billion by 2024 from USD 3.1 billion in 2019, at a CAGR of 10.9% during the forecast period. The market for HCIT integration solutions is primarily driven by the increasing need for integration owing to the rising healthcare co …
- データ作成の世界市場予測（～2021）：プラットフォーム、ツールThe data prep market is estimated to grow from USD 1.46 Billion in 2016 to USD 3.93 Billion by 2021, at a high Compound Annual Growth Rate (CAGR) of 25.2% during the forecast period. Data prep makes use of tools such as data curation, data cataloging, data quality, data ingestion, and data governance to create consistent data of high quality, by eliminating low quality and incorrect data which wou …
- 企業向けモバイルアプリ開発サービスの世界市場About Global Enterprise Mobile App Development Services The enterprise mobile app development market provides many opportunities for app developers. Enterprises are expected to deploy mobile apps in their businesses at an aggressive rate as mobile apps intended for office use are aimed at improving business productivity in addition to enhancing communication and faster exchange of data. Trend of e …
- Sjogren’s Syndrome：グローバル臨床試験レビューH1, 2013Sjogren's Syndrome Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Sjogren’s Syndrome Global Clinical Trials Review, H1, 2013" provides data on the Sjogren’s Syndrome clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Sjogren’s Syndrome. It includes an overview of the trial numbers and their recruitme …
